Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06211296 · ClinicalTrials.gov registry record · NA
The ShortCut™ Continued Access Study Protocol
A NA study of Aortic Stenosis and Valve-in-valve Procedures, sponsored by Pi-cardia.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 4
- Study locations
NCT06211296: Completed NA study of Aortic Stenosis and Valve-in-valve Procedures, sponsored by Pi-cardia.
NCT06211296 is a NA study of Aortic Stenosis and Valve-in-valve Procedures that has completed, run by Pi-cardia. The registered enrollment target is 8 participants, below the 1,362-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06211296, a NA study of Aortic Stenosis and Valve-in-valve Procedures, has completed, sponsored by Pi-cardia.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 4
- Study locations
Study Summary
A Prospective, Multicenter, Non-Randomized, Single-Arm, Open-Label Continued Access Study of the ShortCut™ device (The ShortCut™ CAS).
Primary Outcome
Primary safety endpoint, ShortCut™ device- and/or ShortCut™ procedure-related: Mortality, Stroke
Conditions Studied
Interventions
- DEVICE Shortcut
Study Locations (4)
California
- Los Robles Regional Medical Center - Thousand Oaks
New Jersey
- Morristown Medical Center - Morristown
New York
- Columbia University Medical Center /NYPH - New York
Pennsylvania
- UPMC Pinnacle - Wormleysburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2024-07-03 |
| Est. Completion | 2025-05-12 |
| Phase | NA |
What the finished NCT06211296 record still lists
NCT06211296 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,362-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Aortic Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Shortcut is the first listed.
NCT06211296 reports a single indexed study location in California, New Jersey, New York.
Frequently Asked Questions
What is clinical trial NCT06211296 about?
NCT06211296 is a clinical study titled "The ShortCut™ Continued Access Study Protocol". A Prospective, Multicenter, Non-Randomized, Single-Arm, Open-Label Continued Access Study of the ShortCut™ device (The ShortCut™ CAS).
What is the current status of trial NCT06211296?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2024-07-03. Estimated completion is 2025-05-12.
What conditions does trial NCT06211296 study?
This clinical trial studies the following conditions: Aortic Stenosis, Valve-in-valve Procedures, Coronary; Obstruction.
What interventions are being tested in trial NCT06211296?
The interventions under investigation include: Shortcut (DEVICE).
Who is sponsoring clinical trial NCT06211296?
This trial is sponsored by Pi-cardia, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06211296 being conducted?
This trial has 4 study locations across California, New Jersey, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06211296's enrollment target sits among peer trials
8 25th of 26 higher than 2 of 26 other Aortic Stenosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aortic Stenosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis
RECRUITING · NA
-
Evaluating Infrasonic Hemodynography
RECRUITING · NA
-
Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure
RECRUITING · NA
-
PARTNER 3 Trial - Aortic Valve-in-Valve
RECRUITING · NA
-
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
RECRUITING · NA
-
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI